Clinical Trial Update: Study of SRF617 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating SRF617 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SRF617

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED